Filing Details
- Accession Number:
- 0001209191-20-030479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:28:23
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:28:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Adm, Leg & Bd Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 1 | $273.91 | 26,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 2 | $275.54 | 26,903 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 2 | $276.46 | 26,901 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 1 | $278.69 | 26,900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 11 | $280.34 | 26,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4 | $282.02 | 26,885 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4 | $283.03 | 26,881 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 3 | $284.03 | 26,878 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4 | $285.19 | 26,874 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 9 | $286.27 | 26,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 18 | $287.50 | 26,847 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 9 | $288.23 | 26,838 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $275.54 (range $275.25 to $275.83).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $276.46 (range $276.44 to $276.49).
- Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.74 to $280.73).
- Open market sales reported on this line occurred at a weighted average price of $282.02 (range $281.42 to $282.38).
- Open market sales reported on this line occurred at a weighted average price of $283.03 (range $282.45 to $283.31).
- Open market sales reported on this line occurred at a weighted average price of $284.03 (range $283.56 to $284.37).
- Open market sales reported on this line occurred at a weighted average price of $285.19 (range $284.70 to $285.63).
- Open market sales reported on this line occurred at a weighted average price of $286.27 (range $285.70 to $286.68).
- Open market sales reported on this line occurred at a weighted average price of $287.50 (range $286.96 to $287.88).
- Open market sales reported on this line occurred at a weighted average price of $288.23 (range $287.96 to $288.47).
Billionaire Hedge Funds
